Evidence map›Paper›PMID 32187826›Full record

ArticleEMBO molecular medicine2020

Endothelial Notch signaling controls insulin transport in muscle.

Sana S Hasan, Markus Jabs, Jacqueline Taylor, Lena Wiedmann, Thomas Leibing, Viola Nordström, Giuseppina Federico, Leticia P Roma, Christopher Carlein, Gretchen Wolff and 10 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy.Signal transduction and targeted therapy · 2024 · on this map
    Review
  9. Article
  10. Notch Signaling in the Vasculature: Angiogenesis and Angiocrine Functions.Cold Spring Harbor perspectives in medicine · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Targeting the vasculature in cardiometabolic disease.The Journal of clinical investigation · 2022
    Review
  15. Modulation of endothelium function by fatty acids.Molecular and cellular biochemistry · 2022
    Review
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Sana S Hasan *Division Vascular Signaling and Cancer (A270), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Markus Jabs *Division Vascular Signaling and Cancer (A270), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Jacqueline TaylorDivision Vascular Signaling and Cancer (A270), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lena WiedmannDivision Vascular Signaling and Cancer (A270), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Thomas LeibingDepartment of Dermatology, Venereology, and Allergology, University Medical Center and Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Viola NordströmDivision of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Giuseppina FedericoDivision of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Leticia P RomaBiophysics Department, Center for Human and Molecular Biology (ZHMB), Saarland University, Homburg, Germany.
Christopher CarleinBiophysics Department, Center for Human and Molecular Biology (ZHMB), Saarland University, Homburg, Germany.
Gretchen WolffInstitute for Diabetes and Cancer (IDC) and Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Center Munich, Neuherberg, Germany.
Bilgen Ekim-ÜstünelInstitute for Diabetes and Cancer (IDC) and Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Center Munich, Neuherberg, Germany.
Maik BruneDepartment of Medicine I and Clinical Chemistry, University Hospital of Heidelberg, Heidelberg, Germany.
Iris MollDivision Vascular Signaling and Cancer (A270), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Fabian TetzlaffDivision Vascular Signaling and Cancer (A270), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hermann-Josef GröneDivision of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Thomas FlemingDepartment of Medicine I and Clinical Chemistry, University Hospital of Heidelberg, Heidelberg, Germany.
Cyrill GéraudDepartment of Dermatology, Venereology, and Allergology, University Medical Center and Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Stephan HerzigInstitute for Diabetes and Cancer (IDC) and Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Center Munich, Neuherberg, Germany.ORCID 0000-0003-3950-3652
Peter P NawrothInstitute for Diabetes and Cancer (IDC) and Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Center Munich, Neuherberg, Germany.ORCID 0000-0002-6134-7804
Andreas FischerDivision Vascular Signaling and Cancer (A270), German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-4889-0909
German Cancer Research Center · DEHeidelberg University · DEGerman Center for Diabetes Research · DESaarland University · DEPhilipps University of Marburg · DE

Funding

Chica and Heinz Schaller FoundationDeutsche Forschungsgemeinschaft (DFG) 394046768Deutsche Forschungsgemeinschaft (DFG) FI 1569/3-1Deutsche Forschungsgemeinschaft (DFG) SFB1118Deutsche Forschungsgemeinschaft (DFG) SFB1123Deutsche Forschungsgemeinschaft (DFG) SFB1366 (project C4 and B3)Deutsche Forschungsgemeinschaft (DFG) SFB894
6 · The paper itself

Abstract

The role of the endothelium is not just limited to acting as an inert barrier for facilitating blood transport. Endothelial cells (ECs), through expression of a repertoire of angiocrine molecules, regulate metabolic demands in an organ-specific manner. Insulin flux across the endothelium to muscle cells is a rate-limiting process influencing insulin-mediated lowering of blood glucose. Here, we demonstrate that Notch signaling in ECs regulates insulin transport to muscle. Notch signaling activity was higher in ECs isolated from obese mice compared to non-obese. Sustained Notch signaling in ECs lowered insulin sensitivity and increased blood glucose levels. On the contrary, EC-specific inhibition of Notch signaling increased insulin sensitivity and improved glucose tolerance and glucose uptake in muscle in a high-fat diet-induced insulin resistance model. This was associated with increased transcription of Cav1, Cav2, and Cavin1, higher number of caveolae in ECs, and insulin uptake rates, as well as increased microvessel density. These data imply that Notch signaling in the endothelium actively controls insulin sensitivity and glucose homeostasis and may therefore represent a therapeutic target for diabetes.

Indexed as

InsulinInsulin ResistanceSignal TransductionAnimalsEndothelial CellsGlucoseMiceMuscle, SkeletalReceptors, NotchGlucoseInsulinReceptors, Notchcaveolaeendothelial cellinsulin transportmuscleNotch signaling

Identifiers

PMID32187826
PMCPMC7136962
OpenAlexW3011320556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.